naloxone

| Article

Newswise — Though research shows that medication-assisted treatment can help people who are addicted to opioids, the three drugs approved by the Food and Drug Administration (FDA) are underused, according to a review of current medical data on opioid addiction in the U.S. This review appears in the...

| Podcast

Despite the current opioid crisis, opioids remain the mainstay of analgesic therapy. They are associated with a multitude of side effects, including respiratory depression, pruritus, nausea, vomiting, urinary retention, ileus, and constipation. Beyond certain doses and duration of intake that vary...

| Article

Newswise —  In a new study published in JAMA Network Open, University of Kentucky researchers, in collaboration with researchers from Ferris State University, examined whether legal mandates on naloxone coprescription in certain states increased naloxone dispensing.

Recently, a Federal Drug...

| Article

Newswise — A new study from researchers at the University of Illinois at Chicago finds that only one-third of pharmacies in Philadelphia carry naloxone nasal spray, a medication used to rapidly counter the effects of opioid overdose, and that many of the pharmacies that do carry the drug require...

| Article

In a press release issued Friday, the US Food and Drug Administration (FDA) announced its approval of the first generic formulation of naloxone and said the agency will prioritize its review of other applications for generic variants of products intended to treat opioid overdose. Douglas...

| Article

A study of heroin users in Baltimore concludes that most are aware that fentanyl is likely present in the drug they are using while also acknowledging their unpreparedness to handle an overdose event that is likely to result from their activity. Researchers from Johns Hopkins Bloomberg School of...

Subscribe to naloxone

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.